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ABSTRACT
O BJECTIVE To describe what patients want to know about their medications and how they currently access 
information. To describe how physicians and pharmacists respond to patients’ information needs. To use 
patients’, physicians’, and pharmacists’ feedback to develop evidence-based treatment information sheets.
DESIGN  Qualitative study using focus groups and a grounded-theory approach.
SETTIN G  Three regions of Canada (British Columbia, Nova Scotia, and Ontario).
PARTICIPAN TS Eighty-eight patients, 27 physicians, and 35 pharmacists each took part in one of 19 focus 
groups.
M ETHO D Purposeful and convenience sampling was used. A trained facilitator used a semistructured 
interview guide to conduct the focus groups. Analysis was completed by at least two research-team members.
MAIN FIN DIN G S Patients wanted both general and specific information when considering medication 
treatments. They wanted basic information about the medical condition being treated and specific information 
about side effects, duration of treatment, and range of available treatment options. Physicians and pharmacists 
questioned the amount of side-effect and safety information patients wanted and thought that too much 
information might deter patients from taking their medications. Patients, physicians, and pharmacists 
supported the use of evidence-based treatment information sheets.
CO N CLUSIO N  Patients and clinicians each appear to have a different understanding of what and how much 
information patients should receive about medications. Feedback from patients can be used to develop 
patient-oriented treatment information.
RÉSUMÉ
O BJECTIF Décrire ce que les patients veulent savoir à propos de leurs médications et comment ils accèdent 
actuellement à ces renseignements. Décrire la réaction des médecins et des pharmaciens aux besoins 
d’information des patients. Se servir de la rétroaction des patients, des médecins et des pharmaciens pour 
élaborer des fiches d’information thérapeutique fondées sur des données probantes.
CO N CEPTIO N  Une étude qualitative à l’aide de groupes témoins et une approche à base empirique.
CO N TEXTE Trois régions au Canada (la Colombie-Britannique, la Nouvelle-Écosse et l’Ontario).
PARTICIPAN TS Au total, 88 patients, 27 médecins et 35 pharmaciens ont participé à l’un des 19 groupes 
témoins.
MÉTHO DO LO GIE On a eu recours à des échantillons de commodité sur une base volontaire. Un animateur 
formé à cet égard se servait d’un guide d’entrevue semi-directive pour diriger les discussions des groupes 
témoins. L’analyse a été réalisée par au moins deux membres de l’équipe de recherche.
PRINCIP ALES CONCLUSIONS  Les patients souhaitaient à la fois des renseignements généraux et spécifiques 
lorsqu’ils envisageaient suivre une pharmacothérapie. Ils voulaient de l’information de base sur l’état de santé 
traité et des renseignements précis sur les effets secondaires, la durée du traitement et l’éventail des options 
thérapeutiques. Les médecins et les pharmaciens remettaient en question la quantité d’information que 
voulaient les patients sur les effets secondaires et l’innocuité, et ils étaient d’avis que trop de renseignements 
pourraient décourager les patients de suivre la pharmacothérapie. Les patients, les médecins et les 
pharmaciens appuyaient tous le recours à des fiches de renseignements thérapeutiques fondés sur des 
données probantes.
CO N CLUSIO N  Les patients et les cliniciens semblent ne pas avoir la même opinion sur la nature et la quantité 
de l’information que devraient recevoir les patients sur les pharmacothérapies. La rétroaction reçue des 
patients pourrait servir dans l’élaboration de renseignements thérapeutiques à leur intention.
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O
ne of the most noticeable changes in 
health care over the last few decades has 
been the increased involvement of patients 
in their treatment decisions. Patients want 
and are seeking more information about drug and non-
drug treatment options. While a great deal of patient 
information about medications, treatments, and dis-
eases exists, much of it contains conflicting, inaccurate, 
poorly written, or non–evidence-based information.1-3 
For example, direct-to-consumer advertising by phar-
maceutical companies typically promotes a particular 
product as opposed to providing patients with an 
assessment of a range of therapeutic options.4
Medication counseling programs are often devel-
oped without input from patients, and accordingly, some-
times do not provide the information patients want.5 
The United States Food and Drug Administration had 
set a goal of having 75% of patients receive written 
information about medications by the year 2000, but it 
appears this goal has still not been met.3 A 1994 cross-
sectional national telephone survey demonstrated that 
only 15% of patients at physician offices and 59% of 
patients at pharmacies had received written informa-
tion about medications.6 The need for balanced, acces-
sible patient information still exists.
The Canada Drug Guide study was established to 
develop and test evidence-based patient information 
sheets. The focus group study described here was the 
first phase of this study. The objectives of phase 1 were 
to describe what patients want to know about medi-
cation treatment options and how patients currently 
access information, to describe physicians’ and phar-
macists’ responses to patients’ information needs, and 
to incorporate patients’, physicians’, and pharmacists’ 
feedback into the development of information sheets.
METHODS
Design
This qualitative study used a grounded-theory approach.7 
Focus groups were held with patients, physicians, and 
pharmacists between January and March 1999 in three 
regions of Canada (Ontario, Nova Scotia, and British 
Columbia). Facilitation of the focus groups followed 
accepted methods.8,9    This study received ethics approval 
from the St Joseph’s Healthcare Research Ethics Board 
in Hamilton, Ont, the Dalhousie University Faculty 
of Medicine Research Ethics Community in Halifax, 
NS, and the University of British Columbia Ethics 
Committee in Vancouver, BC.
Study sample
We used a combination of purposeful and convenience 
sampling. Purposeful sampling involves consciously 
seeking out participants who can contribute to the 
subject area.7,10 In this study, it was important that 
participants reflect the cultural and demographic real-
ity of the cities targeted by the study. Once stratifica-
tion of potential participants was devised, convenience 
sampling was then used to recruit patients.7 Through 
contact with community organizations, naturally occur-
ring groups were recruited for the focus groups.
Anyone older than 18 years who had taken at least 
one medication was eligible to participate in the patient 
focus groups. Pharmacists and physicians who had 
practised in a clinical capacity for at least 1 year were 
invited to participate in the study. Sample size was 
estimated in consultation with a qualitative research 
expert. Focus groups were conducted until theoreti-
cal saturation (repetition of themes) was reached.7
Focus group format
Focus groups were chosen because they provided the 
opportunity for different groups of people to share 
their thoughts and ideas. Patient focus groups were 
conducted using an interview guide consisting of 
17 open-ended questions that asked about patients’ 
general medication information needs and for their 
opinions about the draft information sheets. The infor-
mation sheets addressed treatment options for three 
conditions that each represented a broader disease 
classification: sore throat (acute symptomatic), gastro-
esophageal reflux disease (chronic symptomatic), and 
osteoporosis (chronic asymptomatic). Physicians and 
pharmacists were asked for their opinions about the 
themes emerging from the patient focus groups.
The interview guide was pilot-tested to ensure clar-
ity in the order, timing, and wording of questions. The 
guide was modified as themes emerged. All groups 
were audiotaped. At least two research team members 
were present for each group; one member facilitated 
the group, the other took detailed handwritten notes. 
After each group interview, the researchers held a 
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debriefing that included their perceptions of the group 
and any format and process issues that arose. All tapes 
were transcribed and cleaned before data analysis.
Data analysis
Verbatim statements from the audiotapes and debrief-
ing notes were coded to identify common themes. 
Each transcript was coded independently by at least 
two research team members using an operational code 
book. A qualitative data retrieval computer program, 
QSR NUD*IST (version 4.0)11 was used to help orga-
nize the data.
Themes were continually developed and explored 
during data analysis. This iterative analysis strategy 
meant that further analysis was conducted as new 
themes emerged. Summaries of each theme were 
completed by at least two research team members. 
Transcripts and summaries were reviewed to elicit 
both confirming and nonconfirming data for the 
themes being generated. Following completion of the 
theme summaries, three researchers discussed the 
findings to ensure there was consensus for the report.7 
A model was then developed to describe the relation-
ships between the key variables generated.10 This theo-
retical model sought to provide contextual information 
about the factors that influence how patients access 
and evaluate treatment information.
RESULTS
Eighty-eight patients, 27 physicians, and 35 pharma-
cists took part in one of 19 focus groups. Focus groups 
were held in British Columbia (five), Nova Scotia 
(five), and Ontario (nine). At least two patient focus 
groups had one of the following as a dominant charac-
teristic: rural residents, similar ethnic background 
(one Asian group, one Italian group), advanced age, 
low income, and chronic medical conditions. Each 
focus group had between three and 12 participants.
The mean age of patients was 54 years (standard 
deviation [SD] ±19); 75% were women, 29% were work-
ing, and 41% were retired. Participants were taking 
a mean of 2.1 (SD 2.2) medications. Mean number 
of visits to their family physicians in a year was 5.5 
(SD 6.6) and to their pharmacies was 6.4 (SD 7.2).
Of the 27 physicians participating in the focus 
groups, 74% were men, and 93% were family physi-
cians. Of the 35 pharmacists, 43% were men, and 97% 
were community-based.
Patients discussed wanting general information 
about the condition under consideration before they 
made informed decisions about treatment. Many 
patients thought they did not have a strong grasp of 
their diagnoses; when evaluating written information, 
they looked for enough description of the condition so 
that they could be certain the information pertained 
to them. Patients also identified five specific areas 
they wanted information on: side effects and risks, 
range of treatment options, how long to take medica-
tions, cost of medications, and whether the medica-
tion was right for them.
Side-effect and risk information
The need for side-effect and risk information was men-
tioned in all 11 patient focus groups. This category 
included statements about interactions and contraindi-
cations. In most groups, this was the first mention 
of what patients wanted to know about medication. 
Patients expressed frustration about not getting as 
much information about side effects and risks as they 
would like. One patient in a group of young profession-
als noted,
I find that unless I ask the questions to my doctor, that 
she doesn’t always come out and tell me… and after, there 
had been some side effects that I would have thought 
she would have automatically told me about.…
Patients generally believed that full disclosure of 
side-effect information would help them make more 
informed treatment decisions.
Range of treatment options
In almost every group, participants mentioned want-
ing to know about the range of treatment options 
available, including nonpharmacologic and alternative 
remedies. As one patient said, “Most doctors don’t 
give you options, they just say this is what you are tak-
ing.” Patients were also interested in learning about 
self-care strategies they could begin before seeing a 
health care professional (eg, how to manage a sore 
throat). In general, patients thought they had not usu-
ally received this information from their physicians 
or pharmacists and so they used other resources to 
meet their needs.
How long to take medication
Some patients expressed concern about the lack of 
information regarding the length of time they should 
take a medication. In some cases, they were confused 
about whether the suggested medication would need 
to be taken “forever.” Patients also wanted to know 
the typical follow-up process when receiving a medica-
tion prescription, “One thing I was wondering about 
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is the length of time you’re supposed to take it.… I’ve 
been taking it for quite some time, and the doctor 
hasn’t arranged for me to see the doctor who pre-
scribed it.” For these patients, knowing how long they 
would need to take the medication was important infor-
mation for decision making.
Cost of medication
Cost of medication was cited as important in many 
groups. Patients wanted to know whether a medica-
tion was covered by their drug plans and whether 
there were more cost-effective alternatives available.
[T]here’s many brands of the same kind of medication, 
and often the doctor will prescribe one that comes to the 
centre front of his mind just because maybe he’s seen it or 
read about it… and sometimes we don’t think to ask, “well, 
can I get the same kind of medication but in a different 
brand name that would almost cut the cost by a third…”
Is this medication right for me?
Patients were also interested in knowing whether the 
medication prescribed for them was the most appro-
priate for them personally rather than a medication 
that could have been prescribed to anyone with that 
condition. For these patients, it was important to know 
that the treatment under consideration reflected their 
individual health situations.
Sources of information
Patients sought information from a variety of sources. 
Access was the main factor in determining from whom or 
where information was sought. Overwhelmingly, patients 
thought that pharmacists were the most accessible source 
of information because they were typically available when 
patients needed information, “[A]t the pharmacy you can 
always walk right in [at] any time… you’re not disturbing 
a doctor whose time is fairly important;… it’s handier that 
way than a doctor’s office.” Pharmacists and the medica-
tion printouts or pill labels they dispense were patients’ 
most frequently mentioned current source of drug infor-
mation. Patients wanted to ask their doctors about treat-
ment but often found doctors were difficult to access or 
did not have the time to discuss what patients wanted to 
know. Other sources of information included those that 
patients could access on their own time, such as television, 
newspapers, libraries, the Internet, family, and friends.
Clinicians’ response to 
patients’ information needs
Participating physicians and pharmacists demonstrated 
a general understanding of patients’ information needs. 
They expressed concern about the amount of infor-
mation on side effects and other safety issues they 
should provide to patients. They thought that extra 
information on drugs should be given only if it did 
not contribute to information overload, confusion, or 
noncompliance. Clinicians also acknowledged that 
information about treatment options and alternatives 
was important to patients.
Participating clinicians all seemed to be unaware 
that patients wanted treatment information that was 
explicitly personalized for their own unique health situ-
ations. They also did not recognize that patients want 
to know why a particular medication or treatment was 
suggested for them. Pharmacists in all regions raised 
concerns particular to their profession; they thought 
they were at a disadvantage when providing informa-
tion to patients because they often lacked access to the 
diagnosis that engendered a prescription. Both physi-
cians and pharmacists acknowledged the importance 
of written information in affirming oral discussions.
Using feedback to develop 
evidence-based information sheets
The information sheets were initially developed by 
the research team and reflected what the team per-
ceived to be the information patients wanted. As 
the focus groups progressed, changes were made to 
the information sheets to incorporate patients’ prefer-
ences. Three major changes were made: placing basic 
information about the medical condition at the begin-
ning of the sheet, simplifying how numbers and sta-
tistical information were presented, and including 
self-care strategies. The three sheets can be seen at 
www.ti.ubc.ca/canadadrugguide.
Development of a theoretical model
Figure 1 depicts the model developed to help explain 
how patients seek information. The impetus to seek 
information about a medication comes either from hav-
ing a medical condition diagnosed or being prescribed 
a treatment. Several contextual and intervening factors 
can affect whether a patient actively seeks information. 
Finding information might help patients to be more 
informed or to have more useful discussions with their 
physicians and pharmacists. If information is not sought, 
patients cannot be better off and might even be worse 
off in ways that are as yet unknown.
DISCUSSION
This study demonstrates that patients want a range 
of information about treatment options. Patients often 
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thought they did not receive enough information about 
cost, duration of treatment, and what the treatment was 
for. Patients were also consistent in stating their need 
for detailed, comprehensive information about the side 
effects and safety of medications. While physicians and 
pharmacists were generally cognizant of the kinds of 
information patients wanted, they consistently said that 
too much information could be detrimental to patients.
Participating clinicians thought they should be able 
to use their own judgment as to what and how much 
information to pass on to patients. They uniformly recog-
nized, however, that lack of time was their biggest bar-
rier to providing information. It could be that clinicians’ 
bias against providing detailed information is a defence 
against ever more demands on their time; this hypoth-
esis is strengthened by clinicians’ support of providing 
both oral and written information simultaneously. They 
thought written documents could provide more com-
plete information when there is little time for discussion.
Most patients access information from the sources 
most convenient for them. Although physicians remain 
the preferred source of information, other more easily 
accessible sources, such as pharmacists, are con-
sulted if physicians are unavailable. To supplement 
information provided by pharmacists and physicians, 
patients access a variety of human, print, and elec-
tronic sources. Given that some of these sources pro-
vide misinformation, it is important that patients and 
health care professionals discuss medications fully 
before making decisions.
Existing research supports our finding that patients 
have unmet information needs. One qualitative study 
found that the information patients obtained about med-
ications was one factor that influenced adherence.12 
Another study involving gastroenterology patients 
found that 92% wanted more information about medi-
cations.13 A recent study investigating how much infor-
mation about adverse effects patients want found that 
76.2% of 2500 respondents wanted full disclosure of 
all possible adverse effects.14 Current literature pro-
vides conflicting perspectives on whether information 
about side effects leads to poorer compliance or more 
reported side effects. Several studies have found no 
statistically significant differences between groups 
Culture
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role in health care
Context
Diagnosis and
treatment pre-
scribed
Causal condition
Wanting or needing
information about
medication or treat-
ment
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Actively seeking
and evaluating
information
Strategies
More informed
Enhanced 
dialogue with
health care
provider
Consequences
Accessibility
Experience
Condition for which information is sought
Quality of relationship with health care provider
Intervening factors
Figure 1. Model of how and why patients seek information
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No change
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when information about side effects was presented.15-17 
The “adverse effects of talking about adverse effects” 
need to be studied further to determine whether pro-
viding information about medication risks has a nega-
tive effect on health outcomes.
Strengths
This study has several strengths. Many focus groups 
were conducted with a diverse patient sample, which 
facilitated the analysis process to reach saturation. Two 
suggested qualitative verification procedures were car-
ried out7: negative case analysis and investigator triangu-
lation. Negative case analysis, the examination of data 
to find contradictory evidence in an effort to acknowl-
edge the breadth of possible responses,7 is an important 
mechanism to ensure that bias does not unduly affect 
analysis. Investigator triangulation was also used to dimin-
ish bias and to affirm consistency of findings by having 
more than one person conduct the analysis.7
Limitations
Despite the rigour of data collection and analysis, 
this study has limitations. First, while the study was 
large enough to identify strong consistencies across 
groups, it was not large enough to allow saturation 
for identification of subtle differences between sub-
groups (eg, urban vs rural). Second, the use of volun-
teer participants likely resulted in overrepresentation 
of those more interested in patient information needs. 
Finally, most participants in these groups were older 
women. Although this is partly due to specific sam-
pling of seniors and women to comment on the 
osteoporosis guide, our findings likely reflect the pref-
erences of this particular group. Further research 
with men and younger people will help to ascertain 
whether these preferences and needs are uniform 
among different groups.
Conclusion
Both patients and clinicians acknowledge that patients 
need information to make informed decisions about 
treatments. Patients seem to want more information 
about adverse effects than clinicians think they should 
provide. Patients, physicians, and pharmacists sup-
ported the use of evidence-based treatment informa-
tion sheets as a means of reinforcing oral advice. 
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Editor’s key points
• Patients want information about the medications 
they are prescribed, particularly about side effects, 
other therapeutic options, and the length and cost 
of treatment.
• Patients want to know that proposed medications 
are right for them personally. Most patients think 
pharmacists are the most accessible source of 
information.
• Physicians and pharmacists realize that patients 
want information about their medications, but are 
reluctant to discuss side effects in case it leads 
to noncompliance. Clinicians were unaware that 
patients were concerned about medications being 
right for them personally.
• Results of this study were used to help develop 
patient information sheets compatible with patients’ 
information needs.
Points de repère du rédacteur
• Cette étude qualitative décrit les besoins d’infor-
mation des patients face aux médicaments et les 
sources d’information qu’ils utilisent. Ceux-ci veu-
lent avoir des renseignements sur les risques et 
les effets secondaires, les différentes options thé-
rapeutiques, la durée et le coût du traitement.
• Ils veulent également savoir si la médication pro-
posée est appropriée compte tenu de leur état de 
santé personnel. La grande majorité des patients 
estiment que le pharmacien est la source d’infor-
mation la plus accessible.
• Les médecins et les pharmaciens participants sont 
généralement conscients des besoins d’informa-
tion exprimés par les patients. Ils sont toutefois 
réticents à fournir une trop grande quantité d’infor-
mation sur les risques et les effets secondaires, ce 
qui pourrait affecter la fidélité au traitement. Les 
cliniciens ne sont pas conscients que les patients 
désirent discuter du choix d’une médication en 
fonction de leur état de santé personnel.
• Les résultats de cette étude ont servi à déve-
lopper des feuillets d’information tenant compte 
des besoins et des préférences des patients
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